Differential Expression of BARD1 Isoforms in Melanoma
Open Access
- 23 February 2021
- Vol. 12 (2), 320
- https://doi.org/10.3390/genes12020320
Abstract
Melanoma comprises BARD1 splice isoforms in melanoma cell lines and patient tissue samples. Seventy-six BARD1 mRNA variants were identified in total, with several previously characterised isoforms (γ, φ, δ, ε, and η) contributing to a large proportion of the expressed transcripts. In addition, we identified four novel splice events, namely, Δ(E3_E9), ▼(i8), IVS10+131▼46, and IVS10▼176, occurring in various combinations in multiple transcripts. We found that short-read RNA-Seq analyses were limited in their ability to predict isoforms containing multiple non-contiguous splicing events, as compared to long-range nanopore sequencing. These studies suggest that further investigations into the functional significance of the identified BARD1 splice variants in melanoma are warranted.This publication has 44 references indexed in Scilit:
- Epidemiology of MelanomaHematology/Oncology Clinics of North America, 2020
- Treatment of Advanced Melanoma in 2020 and BeyondJournal of Investigative Dermatology, 2020
- Worldwide Increasing Incidences of Cutaneous Malignant MelanomaJournal of Skin Cancer, 2011
- BRCA1/BARD1 Ubiquitinate Phosphorylated RNA Polymerase IIOnline Journal of Public Health Informatics, 2005
- BRCA1-Dependent Ubiquitination of γ-Tubulin Regulates Centrosome NumberMolecular and Cellular Biology, 2004
- BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repairHuman Molecular Genetics, 2004
- Autoubiquitination of the BRCA1·BARD1 RING Ubiquitin LigaseOnline Journal of Public Health Informatics, 2002
- Identification of BARD1 as Mediator between Proapoptotic Stress and p53-Dependent ApoptosisMolecular Cell, 2001
- The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived MutationOnline Journal of Public Health Informatics, 2001
- Identification of a RING protein that can interact in vivo with the BRCA1 gene productNature Genetics, 1996